Insider selling at CHEMOURS: Martinko Joseph T. and senior execs trim 2,000+ shares during a bullish rally—indicating strategic rebalancing, not a warning sign.
Insider Mather’s latest Chemours stock purchase signals confidence in its high‑margin assets and growth strategy—an attractive entry for value investors.